Surgery Partners, Inc. (SGRY) News
Filter SGRY News Items
SGRY News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
SGRY News Highlights
- For SGRY, its 30 day story count is now at 10.
- Over the past 20 days, SGRY's stories per day has been in a clear downtrend, falling by about 0.80 per 2 days.
- PRVA and BEAT are the most mentioned tickers in articles about SGRY.
Latest SGRY News From Around the Web
Below are the latest news stories about Surgery Partners Inc that investors may wish to consider to help them evaluate SGRY as an investment opportunity.
Wall Street Analysts Predict a 35% Upside in Surgery Partners (SGRY): Here's What You Should KnowThe consensus price target hints at a 34.6% upside potential for Surgery Partners (SGRY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. |
Surgery Partners (SGRY) Reports Next Week: Wall Street Expects Earnings GrowthSurgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
Can Surgery Partners (SGRY) Climb 40% to Reach the Level Wall Street Analysts Expect?The average of price targets set by Wall Street analysts indicates a potential upside of 39.5% in Surgery Partners (SGRY). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. |
Surgery Partners, Inc. Announces Fourth Quarter 2021 Earnings Release Date and Conference Call DetailsBRENTWOOD, Tenn., Feb. 04, 2022 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its fourth quarter 2021 results after market close on Monday, February 28, 2022, to be followed by a conference call at 5:00 p.m. (Eastern Time) |
Surgery Partners announces tie-up with Privia Health in MontanaSurgery Partners (SGRY) enters into a strategic agreement with Privia Health (PRVA) whereby SGRY will leverage the physician enablement capabilities of PRVA in Montana.PRVA will build out |
Privia Health Partners with Surgery Partners; Enters Montana MarketARLINGTON, Va. and BRENTWOOD, Tenn., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) and Surgery Partners, Inc. (Nasdaq: SGRY) today announced a strategic agreement whereby Surgery Partners will leverage the physician enablement capabilities of Privia Health in the state of Montana, and Privia Health will build out a statewide physician provider network that will benefit from Surgery Partners high-value surgical capabilities. This agreement marks Privia Health’s entry |
Surgery Partners Enters Strategic Partnership with Privia Health in the State of MontanaBRENTWOOD, Tenn. and ARLINGTON, Va., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (Nasdaq: SGRY) and Privia Health Group, Inc. (Nasdaq: PRVA) today announced a strategic agreement whereby Surgery Partners will leverage the physician enablement capabilities of Privia Health in the state of Montana, and Privia Health will build out a statewide physician provider network that will benefit from Surgery Partners' high-value surgical capabilities. This agreement marks Privia Health’s entry |
Surgery Partners (SGRY) Presents At 40th Annual J.P. Morgan Virtual Healthcare ConferenceNo summary available. |
Foster Victor Wealth Advisors, LLC Buys Vanguard Value ETF, Schwab U.S. ...Investment company Foster Victor Wealth Advisors, LLC (Current Portfolio) buys Vanguard Value ETF, Schwab U.S. |
Save Your Portfolio by Getting Rid of These 4 Toxic StocksInvestors who can spot the overpriced stocks and shun them at the right time are the ones likely to make a profit. SGRY, ASAI, BLKB and AZTA are a few toxic stocks that you should disown right away. |